INTERCEPT PHARMACEUTICALS, INC. Underwriting Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies...
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,...
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Underwriting Agreement, dated April 5, 2018, between Intercept Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) $400,000,000 3.25% Convertible Senior Notes due 2023 UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2016
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,200,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2015
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2015
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) [l]Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2012